Zegalogue

Chemical Namedasiglucagon
Dosage FormInjection (subcutaneous; 0.6 mg/0.6 mL)
Drug ClassAntihypoglycemic agents
SystemBlood
CompanyZealand Pharma
Approval Year2021

Indication

  • For the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above
Last updated on 3/14/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Zegalogue (dasiglucagon) Prescribing Information.2021Zealand Pharma A/S, 2860 Søborg, Denmark